Medicus Pharma: Prostate Cancer Breakthrough Tevevelix FDA Study Greenlit

By Proactive Investors / February 13, 2026 / www.youtube.com / Article Link


Medicus Pharma Ltd has received FDA clearance to launch a Phase 2b study of Teverelix(R) in advanced prostate cancer.

Recent News

Agnico Eagle's production dip and higher costs offset by jump in gold
February 17, 2026 / www.canadianminingreport.com

Barrick, Agnico Eagle report extremely strong Q4/25 results
February 17, 2026 / www.canadianminingreport.com

Metals far outpacing tech over past year
February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery
February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick
February 02, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok